When Chinese authorities accused GlaxoSmithKline last summer of being
the “godfather” at the centre of a network of corruption, big pharma
braced for a prolonged period of turmoil in one of the world’s
您已閱讀4%(199字),剩余96%(4842字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。